arrow
D

Dolors Rodríguez-Pardo

ciberinfec and instituto de salud carlos iii
H指数:41
被引数:6,430

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Extended-pulsed fidaxomicin versus conventional dosing in patients at high risk of recurrence of Clostridioides difficile infection: a multicentre cohort study

延长脉冲剂量的 fidaxomicin 与常规剂量在易复发艰难梭菌感染患者中的比较:一项多中心队列研究

2026-07-110
PRE
Emerging reservoirs of metallo- upbeta-lactamase genes among non-aeruginosa Pseudomonas and Stutzerimonas species in a Spanish tertiary hospital

西班牙某三级医院中非铜绿假单胞菌和Stutzerimonas属中金属β-内酰胺酶基因的新兴储存库

2026-05-220
OAAI
Comparative activity of established versus new-generation β-lactams against AmpC-hyperproducing clinical isolates of Enterobacter cloacae complex and Klebsiella aerogenes: a multicentre study

与新一代β-内酰胺类抗生素相比,已建立药物的活性对比:针对阴沟肠杆菌复合群和费氏柠檬酸杆菌产AmpC酶高表达的临床分离株的多中心研究

2026-02-060
PRE
2025 ICM: Use of Newer Antibiotics and Fluoroquinolone-Resistance

2025年ICM:新抗生素和氟喹诺酮耐药性的应用

2026-01-010
PRE
2025 ICM: Antibiotic Prophylaxis in Primary Joint Arthroplasty

2025 ICM:初次关节置换术中的抗生素预防

2025-10-280
PRE
Impact of antibiotic prophylaxis in second-stage surgery in joint prosthesis infection treated with two-stage exchange. A multicenter case-control study
2024-05-150
PRE
Cutibacterium spp. Infections after Instrumented Spine Surgery Have a Good Prognosis Regardless of Rifampin Use: A Cross-Sectional Study
2023-03-042
OA
Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study
2022-04-118
PRE
arthroplasty revision: A large multicenter cohort
2021-11-019
PREAI
Prosthetic Shoulder Joint Infection by Cutibacterium acnes: Does Rifampin Improve Prognosis? A Retrospective, Multicenter, Observational Study
2021-04-2115
OAAI
Role of asymptomatic bacteriuria on early periprosthetic joint infection after hip hemiarthroplasty. BARIFER randomized clinical trial
2021-04-164
OA
Infections after spine instrumentation: effectiveness of short antibiotic treatment in a large multicentre cohort
2021-01-266
OA